For research use only. Not for therapeutic Use.
Guretolimod hydrochloride is a Toll-like receptor 7 (TLR7) agonist[1].
Catalog Number | I041013 |
Synonyms | 2-[[4-[[2-amino-4-[[(3S)-1-hydroxyhexan-3-yl]amino]-6-methylpyrimidin-5-yl]methyl]-3-methoxyphenyl]methyl-(2,2,2-trifluoroethyl)amino]acetic acid;hydrochloride |
Molecular Formula | C24H35ClF3N5O4 |
Purity | ≥95% |
InChI | InChI=1S/C24H34F3N5O4.ClH/c1-4-5-18(8-9-33)30-22-19(15(2)29-23(28)31-22)11-17-7-6-16(10-20(17)36-3)12-32(13-21(34)35)14-24(25,26)27;/h6-7,10,18,33H,4-5,8-9,11-14H2,1-3H3,(H,34,35)(H3,28,29,30,31);1H/t18-;/m0./s1 |
InChIKey | JJORVDJBDDODOH-FERBBOLQSA-N |
SMILES | CCCC(CCO)NC1=NC(=NC(=C1CC2=C(C=C(C=C2)CN(CC(=O)O)CC(F)(F)F)OC)C)N.Cl |
Reference | [1]. Hori, et al.Preparation of carboxylic acid compounds as TLR-7 agonists.WO2013172479A1 |